Comparing non-invasive biomarkers of non-alcoholic steatohepatitis in obesity
Royce P Vincent(Hammersmith Hospital), Geltrude Mingrone(University of the Sacred Heart), Laura Riccardi(Università Cattolica del Sacro Cuore), Tracey Mare(King's College Hospital NHS Foundation Trust), Maurizio Pompili, Giulia Angelini(Università Cattolica del Sacro Cuore), Simona Panunzi(Istituto di Analisi dei Sistemi ed Informatica Antonio Ruberti), James Luxton(King's College Hospital NHS Foundation Trust), Roux Carel le, Matteo Garcovich(Agostino Gemelli University Polyclinic)
Cited by 0
Related Papers
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Joint international consensus statement for ending stigma of obesity
|Nature Medicine|2020|1.1k
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetologia|2022|986
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
|Diabetes Care|2016|969
Attenuated Peptide YY Release in Obese Subjects Is Associated with Reduced Satiety
|Endocrinology|2005|544